Rapid and Low-Cost Detection and Quantification of SARS-CoV-2 Antibody Titers of ICU Patients with Respiratory Deterioration Using a Handheld Thermo-Photonic Device.

Damber Thapa, Nakisa Samadi, Andrew Baker, Claudia Dos Santos, Uriel Trahtemberg, Nima Tabatabaei

Open access · goldAbstract read

In one paragraph

Article in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

0.2field-weighted citation impact, top 50% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

A Protein Microarray-Based Respiratory Viral Antigen Testing Platform for COVID-19 Surveillance.Biomedicines · 2022
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Damber ThapaDepartment of Mechanical Engineering, York University, Toronto, ON M3J 1P3, Canada.

Nakisa SamadiDepartment of Mechanical Engineering, York University, Toronto, ON M3J 1P3, Canada.

Andrew BakerInterdepartmental Division of Critical Care, St. Michael's Hospital, Toronto, ON M5B 1W8, Canada.

Claudia Dos SantosInterdepartmental Division of Critical Care, St. Michael's Hospital, Toronto, ON M5B 1W8, Canada.

Uriel TrahtembergCritical Care Department, Galilee Medical Center, Nahariya 2210001, Israel.

Nima TabatabaeiDepartment of Mechanical Engineering, York University, Toronto, ON M3J 1P3, Canada.ORCID 0000-0002-0329-4855

St. Michael's Hospital · CAYork University · CA

Funding

Natural Sciences and Engineering Research Council I2IPJ 531925-2018St. Michael's Foundation COVID-19 Longitudinal Biomarkers of Lung Injury study

6 · The paper itself

Abstract

While research suggests that COVID-19 vaccines are effective in producing anti-SARS-CoV-2 antibodies that reduce the risk of COVID-19 and its potentially severe complications, how long these antibodies persist after the infection/vaccination is unknown. Longitudinal studies and rapid and scalable platforms are needed for large-scale sero-diagnosis and vaccine evaluation. In this study, we examine the efficacy of our recently-developed handheld thermo-photonic device for rapid and low-cost assessment of the adaptive immune response of COVID

Indexed as

antibodiescoronavirusCOVID-19lateral flow immunoassayphotothermalSARS-CoV-2

Identifiers

PMID35740446

DOI10.3390/biomedicines10061424

PMCPMC9220023

OpenAlexW4282968748

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.